FMT is a therapeutic method where healthy gut bacteria from a carefully screened donor are transferred to someone with an imbalanced or damaged microbiome. The goal is to restore a healthy microbial ecosystem that can:

• improve digestion and nutrient absorption
  
• strengthen the immune system
  
• reduce inflammation
  
• support metabolic and mental health

FMT is already used in clinical settings around the world, especially for patients with chronic gut infections such as Clostridioides difficile. Research also shows that FMT can improve other conditions such as inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), metabolic issues, allergies, autoimmune diseases, and gut-brain axis disorders such as anxiety, depression, sleep disorders.

Our goal is to make FMT safe and accessible to all patients in Germany and Europe.

FMT Capsules

Traditional FMT is most commonly administered as a liquid suspension delivered via colonoscopy, endoscopic procedures, or rectal enemas. While effective, these methods are invasive, require clinical facilities and medical personnel, and can be uncomfortable or even distressing for patients. Moreover, such procedures are not ideal when treatment requires multiple administrations over time, as each session demands scheduling, preparation, and recovery.

Our approach offers a modern alternative by delivering FMT in the form of orally administered capsules. This format significantly improves the patient experience. Capsules can be taken at home without the need for invasive procedures or hospital visits, making the process more discreet, convenient, and accessible. Capsules allow for controlled, repeated dosing regimens which is often necessary for microbiome reconstruction without subjecting patients to repeated clinical interventions. 

Donors

The quality and safety of FMT depend entirely on the health of the donor. For this reason, every potential donor goes through a strict selection and testing process before entering our program. First, donors complete a detailed health and lifestyle questionnaire to rule out risk factors such as recent antibiotic use, chronic illnesses, gastrointestinal problems, or travel to high-risk regions.

Candidates who pass this initial check undergo comprehensive laboratory testing. Stool samples are screened for a wide range of harmful bacteria, viruses, and parasites, including major gastrointestinal pathogens. In addition, donors undergo blood tests for infectious diseases such as HIV, hepatitis, and other relevant blood-borne infections.

Donor approval is not permanent. All active donors are regularly re-evaluated, and each donation cycle is accompanied by repeated testing and health monitoring. If any irregularity or positive result appears, the donor is immediately excluded from the program and their material is not used.

This strict screening process ensures that only healthy, carefully controlled donors contribute to our products, providing patients with the highest possible safety.

Are you interested to become a donor? Click here.

Personalization

Not all patients benefit equally from the same microbial composition. Traditional FMT often uses a single donor or a fixed donor pool for all recipients, which may help restore gut balance in a general sense but does not account for specific microbial deficits in individual patients.

We are developing a personalized matching approach designed to significantly improve treatment outcomes. As part of this premium service, each patient will undergo gut microbiome sequencing to analyze their unique microbial profile. This analysis allows us to identify which bacterial groups are missing, present in low abundance, or otherwise functionally weakened.

Based on these findings, the patient is matched with the most suitable donor or donor combination from our biobank who are specifically chosen to complement their microbial needs rather than providing a one-size-fits-all solution. By tailoring donor selection to the individual, we aim to increase the effectiveness of FMT, support longer-lasting microbiome restoration, and move toward a more precise, data-driven treatment method.

This personalized matching service will be a higher-standard offering requiring diagnostic sequencing before treatment, providing patients with a more targeted therapeutic approach and potentially faster, more reliable results.

Bring Your Own Donor

Some patients feel more comfortable receiving donor material from someone they personally know, such as a family member, partner, or close friend. We offer an optional “Bring Your Own Donor” service, allowing us to prepare capsules from a donor of your choice.

However, personal familiarity does not replace medical safety standards. Any private donor must undergo the exact same medical screening as our registered donors, including health questionnaires, stool pathogen testing, and blood tests for infectious diseases. Only individuals who meet all safety criteria can be approved. If the donor fails any part of the screening, their sample cannot be used without any exception.

This option gives patients additional flexibility and emotional reassurance while maintaining the highest level of clinical safety.

Availability

Our capsule-based FMT treatment is not available yet. We are working closely with The Federal Institute for Drugs and Medical Devices (BfArM) to obtain official authorization. Our goal is to make this therapy legally and safely available in Germany as soon as possible. However, regulatory approval is a complex process designed to protect patients, and it cannot (and should not) be rushed.

We currently expect availability in early 2027. This timeline may shift depending on regulatory requirements, safety assessments, and ongoing coordination with authorities, but our priority remains full compliance and patient safety.

In the meantime, patients should be cautious. Some companies from the Netherlands and Slovakia are already offering FMT products to customers in Germany without having a German license or regulatory approval. Such products may not meet the safety and quality standards required by German law, and using unregulated material can lead to poor treatment outcomes or, in the worst case, carry risks such as infection transmission.

We strongly recommend waiting for our approved product, which will be produced under high safety standards, screened donors, and approved by The Federal Institute for Drugs and Medical Devices (BfArM) to ensure effectiveness and patient protection.

If you wish to receive updates, including launch announcements, research developments, and opportunities for early access, you may sign up here.